10 Best Short Squeeze Stocks to Buy According to Analysts
Stock market trading has an ever-changing environment. Short squeeze is among the few phenomena capable of capturing and holding the attention of such markets.
Taysha Gene Therapies Inc. (TSHA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 245,254 | $340,903 | 0% | |
| 2. | BIT Capital GmbH Jan Beckers | 117,062 | $162,716 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.25 | 1,333,333 | 1,333,333 | 2024-06-27 | Filing | ||
| $1.63 | 100,000 | Large Shareholder | 16,566,667 | 2023-11-17 | Filing | |
| $0.90 | 16,466,667 | Large Shareholder | 16,466,667 | 2023-08-16 | Filing | |
| $0.90 | 388,889 | Director | 999,381 | 2023-08-16 | Filing | |
| $0.90 | 388,889 | Director | 884,290 | 2023-08-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.33 | 33,000 | Officer | 258,042 | 2023-08-24 | Filing | |
| $0.70 | 5,344 | 8,871,747 | 2023-07-13 | Filing | ||
| $0.71 | 80,528 | 8,877,091 | 2023-07-12 | Filing | ||
| $0.70 | 18,100 | Large Shareholder | 8,957,619 | 2023-06-23 | Filing | |
| $0.70 | 10,508 | Large Shareholder | 8,975,719 | 2023-06-22 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,589,178 | $18,888,958 | 0% | |
| 2. | 8,770,921 | $12,191,580 | 0% | |
| 3. | 640,882 | $890,826 | 0.06% | |
| 4. | 547,128 | $760,508 | 0% | |
| 5. | 453,420 | $630,254 | 0% |
News See All
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, good morning. And welcome to the Taysha Gene Therapies full year 2024. At this time, all participants are in a listen-only mode.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q3 2024 Earnings Call Transcript
Operator: Greetings. And welcome to the Taysha Gene Therapies’ Third Quarter 2024 Earnings Call. At this time, all participants are in listen-only mode.
10 Most Promising Biotech Stocks According to Hedge Funds
Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.
7 Best NASDAQ Stocks Under $5
A Yahoo Finance report on September 28 reveals that consumers are beginning to feel the effects of a cooling labor market, according to the latest Consumer Confidence Index, which shows a narrowing gap...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q2 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Taysha Gene Therapies Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Taysha Gene Therapies, Inc.
9 Best Gene Therapy Stocks to Buy Now
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and understand the reasons behind...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q1 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Taysha Gene Therapies First Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcript
Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $0.92, expectations were $-0.09.
Billionaire Hedge Funds
